ISCE 2026
Powerful Medical anchored a dedicated session on acute coronary occlusion beyond ST-elevation. Stephen W. Smith, José Nunes de Alencar, Pendell Meyers and Robert Herman each presented on the OMI paradigm — from its clinical rationale and common objections to real-world Queen of Hearts cases and the multicentre validation and global implementation of AI-driven OMI detection.
Tucson, Arizona, USA
March 23–27, 2026
The International Society for Computerized Electrocardiology, founded in 1984, is devoted to the advancement of electrocardiology through the application of computer methods. Its annual scientific conference brings together scientists, clinicians, engineers, regulators and industry working on the ECG — and 2026 marked the society's 50th annual meeting.
The conference is designed in the Gordon format: attendance is limited to roughly 125 participants, with morning sessions and ample free time built in to encourage informal exchange between academia, industry and regulatory bodies. Topics range from ECG machine learning and signal processing to algorithms, regulatory issues and ECG in acute coronary syndromes.
- Venue: Omni Tucson National Resort, Tucson, Arizona, USA
- Organiser: International Society for Computerized Electrocardiology (ISCE)
- Website: isce.org
Share this article
About PMcardio
PMcardio features FDA-authorized and CE-marked AI ECG models that interpret any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.